8-K
Current Report
Lineage Cell Therapeutics, Inc. Filed Acc 0001144204-06-012440
Material agreement
- Item 1.01 Entry into a material definitive agreement
From the SEC's structured data for this filing
Loading v039086_8-k.htm…